Jyothy Labs sees Q2 revenue growth despite market challenges

Jyothy Labs announced a 0.4% increase in standalone revenue from operations to INR 736 crores for Q2 FY26, with volumes growing by 2.8%. For H1 FY26, revenue rose by 0.9% to INR 1,487 crores, with volumes up 3.2%. Operating EBITDA for Q2 FY26 stood at 16.1% (INR 118.3 crores) and 16.3% (INR 242.4 crores) for H1 FY26, experiencing a decline from the previous year, partly due to a reduction in gross margin from 50.2% to 48.1% in Q2, and from 50.8% to 48% in H1. PAT for Q2 was INR 87.8 crores, down from INR 104.9 crores year-over-year.

The company managed a GST 2.0 transition and rate reduction, which triggered short-term channel destocking. Modern trade and e-commerce channels grew, while general trade remained soft. Strategic initiatives included the launch of Dr. Wool, an expert liquid detergent for woollens and delicates, expanding its fabric care portfolio into a premium niche. The company also focused on strengthening Maxo Aerosols and Anti-Mosquito Racquet launches through expanded distribution.

Jyothy Labs aims to sustain brand investment and innovation momentum, anticipating sequential growth driven by GST impact normalization and improving demand. Modern and digital channels are expected to lead, complemented by gradual recovery in general trade.